Free Testosterone and Cardiometabolic Parameters in Men: Comparison of Algorithms

Overview

Journal Endocr Connect

Specialty Endocrinology

Date 2021 Feb 5

PMID 33544092

Citations 3

Authors

Stine A Holmboe

Ravi Jasuja

Brian Lawney

Laerke Priskorn

Niels Joergensen

Allan Linneberg

Tina Kold Jensen

Niels Erik Skakkebaek

Anders Juul

Anna-Maria Andersson

Affiliations

Soon will be listed here.

Abstract

Objective: Calculating the free testosterone level has gained increasing interest and different indirect algorithms have been suggested. The objective was to compare free androgen index (FAI), free testosterone estimated using the linear binding model (Vermeulen: cFTV) and the binding framework accounting for allosterically coupled SHBG monomers (Zakharov: cFTZ) in relation to cardiometabolic conditions.

Design: A prospective cohort study including 5350 men, aged 30-70 years, participating in population-based surveys (MONICA I-III and Inter99) from 1982 to 2001 and followed until December 2012 with baseline and follow-up information on cardiometabolic parameters and vital status.

Results: Using age-standardized hormone levels, FAI was higher among men with baseline cardiometabolic conditions, whereas cFTV and cFTZ levels were lower compared to men without these conditions as also seen for total testosterone. Men in highest quartiles of cFTV or cFTZ had lower risk of developing type 2 diabetes (cFTV: HR = 0.74 (0.49-1.10), cFTZ: HR = 0.59 (0.39-0.91)) than men in lowest quartile. In contrast, men with highest levels of FAI had a 74% (1.17-2.59) increased risk of developing type 2 diabetes compared to men in lowest quartile.

Conclusion: The association of estimated free testosterone and the studied outcomes differ depending on algorithm used. cFTV and cFTZ showed similar associations to baseline and long-term cardiometabolic parameters. In contrast, an empiric ratio, FAI, showed opposite associations to several of the examined parameters and may reflect limited clinical utility.

Citing Articles

Testosterone levels and risk of newly diagnosed type 2 diabetes mellitus in adult men: systematic review and meta-analysis.

Vasquez-Tirado G, Guarniz-Salavarria J, Quispe-Castaneda C, Contreras-Cabrera J, Cuadra-Campos M, Meregildo-Rodriguez E Endocrine. 2024; 87(2):362-377.

PMID: 39251467 DOI: 10.1007/s12020-024-04019-4.

Pre-diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank.

Lim J, Hashemian M, Blechter B, Roger V, Wong J Eur J Heart Fail. 2024; 26(3):540-550.

PMID: 38528787 PMC: 11096034. DOI: 10.1002/ejhf.3189.

The role of male hypogonadism, aging, and chronic diseases in characterizing adult and elderly men with erectile dysfunction: a cross-sectional study.

Lisco G, Triggiani V, Bartolomeo N, Ramunni M, Pelusi C, De Pergola G Basic Clin Androl. 2023; 33(1):5.

PMID: 37020191 PMC: 10077617. DOI: 10.1186/s12610-022-00182-8.

References

Jorgensen T, Borch-Johnsen K, Thomsen T, Ibsen H, Glumer C, Pisinger C . A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil. 2003; 10(5):377-86. DOI: 10.1097/01.hjr.0000096541.30533.82. View

Brand J, Rovers M, Yeap B, Schneider H, Tuomainen T, Haring R . Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS One. 2014; 9(7):e100409. PMC: 4096400. DOI: 10.1371/journal.pone.0100409. View

Holmboe S, Vradi E, Jensen T, Linneberg A, Husemoen L, Scheike T . The Association of Reproductive Hormone Levels and All-Cause, Cancer, and Cardiovascular Disease Mortality in Men. J Clin Endocrinol Metab. 2015; 100(12):4472-80. DOI: 10.1210/jc.2015-2460. View

Rosner W, Auchus R, Azziz R, Sluss P, Raff H . Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2006; 92(2):405-13. DOI: 10.1210/jc.2006-1864. View

Helweg-Larsen K . The Danish Register of Causes of Death. Scand J Public Health. 2011; 39(7 Suppl):26-9. DOI: 10.1177/1403494811399958. View

Roy P, Alevizaki M, Huhtaniemi I . In vitro bioassays for androgens and their diagnostic applications. Hum Reprod Update. 2007; 14(1):73-82. DOI: 10.1093/humupd/dmm038. View

Holmboe S, Jensen T, Linneberg A, Scheike T, Thuesen B, Skakkebaek N . Low Testosterone: A Risk Marker Rather Than a Risk Factor for Type 2 Diabetes. J Clin Endocrinol Metab. 2016; 101(8):3180-90. DOI: 10.1210/jc.2016-1778. View

Rauh M . Steroid measurement with LC-MS/MS. Application examples in pediatrics. J Steroid Biochem Mol Biol. 2009; 121(3-5):520-7. DOI: 10.1016/j.jsbmb.2009.12.007. View

Fiers T, Wu F, Moghetti P, Vanderschueren D, Lapauw B, Kaufman J . Reassessing Free-Testosterone Calculation by Liquid Chromatography-Tandem Mass Spectrometry Direct Equilibrium Dialysis. J Clin Endocrinol Metab. 2018; 103(6):2167-2174. DOI: 10.1210/jc.2017-02360. View

10.

Rastrelli G, ONeill T, Ahern T, Bartfai G, Casanueva F, Forti G . Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS. Clin Endocrinol (Oxf). 2018; 89(4):459-469. DOI: 10.1111/cen.13756. View

11.

Wu F, Tajar A, Beynon J, Pye S, Silman A, Finn J . Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010; 363(2):123-35. DOI: 10.1056/NEJMoa0911101. View

12.

Ho C, Stoddart M, Walton M, Anderson R, Beckett G . Calculated free testosterone in men: comparison of four equations and with free androgen index. Ann Clin Biochem. 2006; 43(Pt 5):389-97. DOI: 10.1258/000456306778520115. View

13.

Travison T, Araujo A, Kupelian V, ODonnell A, McKinlay J . The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2006; 92(2):549-55. DOI: 10.1210/jc.2006-1859. View

14.

Antonio L, Wu F, ONeill T, Pye S, Ahern T, Laurent M . Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone. J Clin Endocrinol Metab. 2016; 101(7):2647-57. DOI: 10.1210/jc.2015-4106. View

15.

Avvakumov G, Grishkovskaya I, Muller Y, Hammond G . Resolution of the human sex hormone-binding globulin dimer interface and evidence for two steroid-binding sites per homodimer. J Biol Chem. 2001; 276(37):34453-7. DOI: 10.1074/jbc.M106274200. View

16.

Lerchbaum E, Pilz S, Trummer C, Schwetz V, Pachernegg O, Heijboer A . Vitamin D and Testosterone in Healthy Men: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2017; 102(11):4292-4302. DOI: 10.1210/jc.2017-01428. View

17.

Huang Y, Liu W, Chen S, Liu Y, Chen B, Deng C . Free testosterone correlated with erectile dysfunction severity among young men with normal total testosterone. Int J Impot Res. 2018; 31(2):132-138. DOI: 10.1038/s41443-018-0090-y. View

18.

Olsman N, Goentoro L . Allosteric proteins as logarithmic sensors. Proc Natl Acad Sci U S A. 2016; 113(30):E4423-30. PMC: 4968753. DOI: 10.1073/pnas.1601791113. View

19.

Gerdes L, Bronnum-Hansen H, Madsen M, Borch-Johnsen K, Jorgensen T, Sjol A . Trends in selected biological risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992. J Clin Epidemiol. 2000; 53(4):427-34. DOI: 10.1016/s0895-4356(99)00193-6. View

20.

Soeborg T, Frederiksen H, Mouritsen A, Holm Johannsen T, Main K, Jorgensen N . Sex, age, pubertal development and use of oral contraceptives in relation to serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, Δ4-androstenedione, testosterone and their ratios in children, adolescents and young adults. Clin Chim Acta. 2014; 437:6-13. DOI: 10.1016/j.cca.2014.06.018. View